Security
Option Care Health, Inc. Common Stock · OPCH
OPCHNASDAQCommon stockCurrentCIK 1014739Updated Oct 7, 2026
Name history
BioScrip, Inc. · through Aug 2, 2019MIM CORP · through Mar 14, 2005
OPCH price & chart
Loading TradingView…
NASDAQ:OPCH on TradingView ↗About the company
Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 8,000 team members including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com.
In the news
Option Care Health to Participate in Upcoming Investor Conferences ↗
Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026 ↗
Recent filings
DEFA14A filing
DEFA14A filing
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
SCHEDULE 13G/A - filed by Durable Capital Partners LP regarding Option Care Health, Inc.
10-Q filing
Show 5 more recent filings
Results of Operations and Financial Condition
Items 2.02, 9.01
4 filing
Submission of Matters to a Vote of Security Holders
Items 5.07
4 filing
Regulation FD Disclosure
Items 7.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 3,455,769,000Source | 3,421,743,000Source | 3,217,035,000Source | 3,112,936,000Source |
| Property, Plant and Equipment, NetUSD | 139,236,000Source | 127,367,000Source | 120,630,000Source | 108,321,000Source |
| GoodwillUSD | 1,606,743,000Source | 1,540,246,000Source | 1,540,246,000Source | 1,533,424,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 232,624,000Source | 412,565,000Source | 343,849,000Source | 294,186,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 473,566,000Source | 409,733,000Source | 377,658,000Source | 377,542,000Source |
| Inventory, NetUSD | 471,149,000Source | 388,131,000Source | 274,004,000Source | 224,281,000Source |
| Assets, CurrentUSD | 1,264,968,000Source | 1,322,627,000Source | 1,094,255,000Source | 994,339,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 87,629,000Source | 112,198,000Source | 98,744,000Source | 98,330,000Source |
| Operating Lease, Right-of-Use AssetUSD | 91,250,000Source | 86,528,000Source | 84,159,000Source | 72,424,000Source |
| Other Assets, NoncurrentUSD | 44,394,000Source | 43,965,000Source | 42,349,000Source | 40,313,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 2,129,376,000Source | 2,017,505,000Source | 1,795,363,000Source | 1,726,833,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 18,000Source | 18,000Source | 18,000Source | 18,000Source |
| Retained Earnings (Accumulated Deficit)USD | 876,921,000Source | 669,336,000Source | 457,513,000Source | 190,423,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 4,106,000Source | 11,047,000Source | 14,978,000Source | 21,159,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,326,393,000Source | 1,404,238,000Source | 1,421,672,000Source | 1,386,103,000Source |
| Additional Paid in Capital, Common StockUSD | 1,263,549,000Source | 1,231,435,000Source | 1,204,270,000Source | 1,176,906,000Source |
| Liabilities and EquityUSD | 3,455,769,000Source | 3,421,743,000Source | 3,217,035,000Source | 3,112,936,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 829,348,000Source | 780,146,000Source | 618,309,000Source | 565,351,000Source |
| Operating Lease, Liability, CurrentUSD | 23,996,000Source | 22,044,000Source | 18,278,000Source | 19,380,000Source |
| Accounts Payable, CurrentUSD | 639,829,000Source | 610,779,000Source | 426,513,000Source | 378,763,000Source |
| Operating Lease, Liability, NoncurrentUSD | 88,519,000Source | 84,776,000Source | 85,484,000Source | 71,441,000Source |
| Deferred Income Tax Liabilities, NetUSD | 56,019,000Source | 47,576,000Source | 34,920,000Source | 22,154,000Source |
| Other Liabilities, NoncurrentUSD | 1,438,000Source | 366,000Source | 0Source | 9,683,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 56,019,000Source | 47,576,000Source | 34,920,000Source | 22,154,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 6,780,000Source | 6,512,000Source | 6,000,000Source | 6,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 1,154,052,000Source | 1,104,641,000Source | 1,056,650,000Source | 1,058,204,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 67,538,000Source | 60,909,000Source | 59,201,000Source | 60,565,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 39,956,000Source | 36,143,000Source | 30,479,000Source | 16,783,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in InventoriesUSD | 81,469,000Source | 114,127,000Source | 51,000,000Source | 41,010,000Source |
| Deferred Income Tax Expense (Benefit)USD | 8,443,000Source | 12,656,000Source | 12,766,000Source | 49,187,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 258,447,000Source | 323,392,000Source | 371,295,000Source | 267,547,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 117,247,000Source | 0Source | 12,494,000Source | 87,364,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -161,083,000Source | -36,470,000Source | -56,506,000Source | -108,052,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | 2,529,000Source | 864,000Source | 5,889,000Source | 0Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 41,307,000Source | 35,606,000Source | 41,866,000Source | 35,358,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 10,599,000Source | 12,382,000Source | — | — |
| Payments for Repurchase of Common StockUSD | 309,951,000Source | 252,726,000Source | 250,261,000Source | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -277,305,000Source | -218,206,000Source | -265,126,000Source | 15,268,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | 2,345,000Source | 3,404,000Source | -5,750,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -179,941,000Source | 68,716,000Source | 49,663,000Source | 174,763,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 232,624,000Source | 412,565,000Source | 343,849,000Source | 294,186,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 64,658,000Source | 71,553,000Source | 69,804,000Source | 50,372,000Source |
| Income Taxes Paid, NetUSD | 67,287,000Source | 64,522,000Source | 75,241,000Source | 13,438,000Source |
| Additional Financial Items | ||||
| Amortization of Debt Issuance Costs and DiscountsUSD | 4,147,000Source | 4,628,000Source | 4,446,000Source | 4,304,000Source |
| Amortization of Intangible AssetsUSD | 36,900,000Source | 34,400,000Source | 34,200,000Source | 32,900,000Source |
| DepreciationUSD | 33,758,000Source | 29,093,000Source | 27,819,000Source | 32,243,000Source |
| Depreciation, Amortization and Accretion, NetUSD | 70,690,000Source | 63,498,000Source | 62,200,000Source | 65,434,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | 10,974,000Source | 1,090,000Source |
| Gain (Loss) on Disposition of Other AssetsUSD | — | 0Source | 0Source | 9,403,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | -4,744,000Source | -377,000Source | 0Source | 0Source |
| GoodwillUSD | 1,606,743,000Source | 1,540,246,000Source | 1,540,246,000Source | 1,533,424,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Income (Loss) from Equity Method InvestmentsUSD | 7,409,000Source | 5,964,000Source | 5,530,000Source | 5,125,000Source |
| Income Tax Expense (Benefit)USD | 75,315,000Source | 71,776,000Source | 91,652,000Source | 55,212,000Source |
| InterestExpenseNonoperatingUSD | 54,558,000Source | 49,029,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | 207,585,000Source | 211,823,000Source | 267,090,000Source | 150,556,000Source |
| Nonoperating Income (Expense)USD | -55,006,000Source | -38,234,000Source | — | — |
| Operating ExpensesUSD | 749,989,000Source | 691,160,000Source | 666,628,000Source | 626,687,000Source |
| Operating Lease, ExpenseUSD | 35,100,000Source | 32,700,000Source | 30,600,000Source | 29,100,000Source |
| Other Nonoperating Income (Expense)USD | -7,857,000Source | 4,831,000Source | 89,865,000Source | 14,218,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | 0Source |
| Proceeds from Stock Options ExercisedUSD | 0Source | 0Source | 0Source | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 5,649,519,000Source | 4,911,591,000Source | 4,302,324,000Source | 3,944,735,000Source |
| Cost of RevenueUSD | 4,561,624,000Source | 3,985,209,000Source | 3,321,101,000Source | 3,077,817,000Source |
| Selling, General and Administrative ExpenseUSD | 682,451,000Source | 630,251,000Source | 607,427,000Source | 566,122,000Source |
| Operating Income (Loss)USD | 337,906,000Source | 321,833,000Source | 314,595,000Source | 240,231,000Source |
| Other Nonoperating Income (Expense)USD | -7,857,000Source | 4,831,000Source | 89,865,000Source | 14,218,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 282,900,000Source | 283,599,000Source | 358,742,000Source | 205,768,000Source |
| Income Tax Expense (Benefit)USD | 75,315,000Source | 71,776,000Source | 91,652,000Source | 55,212,000Source |
| Net Income (Loss) Attributable to ParentUSD | 207,585,000Source | 211,823,000Source | 267,090,000Source | 150,556,000Source |
| Earnings Per Share, BasicUSD per share | 1.28Source | 1.23Source | 1.49Source | 0.83Source |
| Earnings Per Share, DilutedUSD per share | 1.27Source | 1.23Source | 1.48Source | 0.83Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 162,099,000Source | 171,567,000Source | 178,973,000Source | 181,105,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 163,365,000Source | 172,845,000Source | 180,375,000Source | 182,075,000Source |
| Interest Expense (non-operating)USD | 54,558,000Source | 49,029,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 36,900,000Source | 34,400,000Source | 34,200,000Source | 32,900,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | 1,087,895,000Source | 1,012,993,000Source | 981,223,000Source | 866,918,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 7,409,000Source | 5,964,000Source | 5,530,000Source | 5,125,000Source |
| Interest ExpenseUSD | — | — | 51,248,000Source | 53,806,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | 44,147,000Source | -34,463,000Source |
| Investment Income, NetUSD | 7,409,000Source | 5,964,000Source | 5,530,000Source | 5,125,000Source |
| Labor and Related ExpenseUSD | — | 787,922,000Source | — | — |
| Nonoperating Income (Expense)USD | -55,006,000Source | -38,234,000Source | — | — |
| Operating ExpensesUSD | 749,989,000Source | 691,160,000Source | 666,628,000Source | 626,687,000Source |
| Operating Lease, ExpenseUSD | 35,100,000Source | 32,700,000Source | 30,600,000Source | 29,100,000Source |
| Other Cost and Expense, OperatingUSD | — | 380,803,000Source | — | — |
| Other IncomeUSD | — | 86,611,000Source | — | — |
Filing attachments
tm2627097d1_ex99-1.htm · DEFA14A · 2026-10-06
Exhibit 99.1 CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health NEW YORK, IRVING, Texas and BANNOCKBURN, Ill., October 6, 2026 - CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health, an independent provider of home and alternate site infusion services, for $32.05 per share, re…
Read attachment ↗tm2627097d1_ex99-1.htm · 8-K · 2026-10-06
Exhibit 99.1 CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health NEW YORK, IRVING, Texas and BANNOCKBURN, Ill., October 6, 2026 - CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have entered into a definitive agreement, under which CD&R and McKesson will acquire Option Care Health, an independent provider of home and alternate site infusion services, for $32.05 per share, re…
Read attachment ↗tm2614211d1_ex99-1.htm · 8-K · 2026-05-12
EX-99.1 2 tm2614211d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Extraordinary Care That Changes Lives © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Option Care Health, Inc. Bank of America Global Healthcare Conference May 12, 2026 1 © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Disclaimers Forward - Looking Statements This presentation may contain “forward - looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1…
Read attachment ↗tm2613077d1_ex99-1.htm · 8-K · 2026-04-30
EX-99.1 2 tm2613077d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE FIRST QUARTER ENDED MARCH 31, 2026 BANNOCKBURN, IL., April 30, 2026 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights (year-over-year compa…
Read attachment ↗tm2613077d1_ex99-2.htm · 8-K · 2026-04-30
EX-99.2 3 tm2613077d1_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Extraordinary Care That Changes Lives Option Care Health, Inc. Q1 2026 Earnings Call April 30, 2026 1 © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Disclaimers Forward - Looking Statements This presentation may contain “forward - looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward - lookin…
Read attachment ↗ex41-12312025x10k.htm · 10-K · 2026-02-24
EXHIBIT 4.1 DESCRIPTION OF CAPITAL STOCK The following is a brief description of the capital stock of Option Care Health, Inc., a Delaware corporation (the “Company,” “we,” “us,” or “our”). The brief description is based on our Fourth Restated Certificate of Incorporation (our “charter”), amended and restated bylaws (our “bylaws”), and provisions of applicable law. The following description does not purport to be complete and is subject to, and qualified in its entirety by, the full text of ou…
Read attachment ↗